In a meta-analysis published in the International Journal of Obesity in 2023 that looked at 5800 people, 78% lost 5% or more of their body weight
Improvement in fibrosis 1 stage without worsening of NASH was achieved in 26% with 30 mg and in 27% with 44 mg, versus 7% with placebo (p = 0.009 and p = 0.008), and resolution of NASH without worsening of fibrosis in 23% with 30 mg, 26% with 44 mg, and 37% with 15 mg, versus 2% with placebo
Each week, the dose is typically increased by 0.6 mg until the recommended daily dose of 3.0 mg is reached
The anti-inflammatory effects of this specifically target this process, reducing inflammatory damage, shortening recovery time, lowering the risk of inflammation-related complications, and preserving the function of multiple organ systems
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy
As a consequence of the inhibition of G6PDH, tumor cells are less able to produce the NADPH necessary to handle the increased oxidative stress of the tumor microenvironment